Ganetespib inhibited tumor growth in a murine MCT xenograft model, while STA-1474 induced tumor regression, caspase-3 activation and downregulation of phospho-Met (pMet)/Met and p-Akt/Akt in OSA xenografts[14], [15]. This evidence concerns the gene AKT1 and neoplasm.